TY - JOUR
T1 - A neutrophil–B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4
AU - Gawish, Riem
AU - Maier, Barbara
AU - Obermayer, Georg
AU - Watzenboeck, Martin L.
AU - Gorki, Anna Dorothea
AU - Quattrone, Federica
AU - Farhat, Asma
AU - Lakovits, Karin
AU - Hladik, Anastasiya
AU - Korosec, Ana
AU - Alimohammadi, Arman
AU - Mesteri, Ildiko
AU - Oberndorfer, Felicitas
AU - Oakley, Fiona
AU - Brain, John
AU - Boon, Louis
AU - Lang, Irene
AU - Binder, Christoph J.
AU - Knapp, Sylvia
N1 - Publisher Copyright:
© 2022, eLife Sciences Publications Ltd. All rights reserved.
PY - 2022/9
Y1 - 2022/9
N2 - Sepsis is a life-threatening condition characterized by uncontrolled systemic inflammation and coagulation, leading to multiorgan failure. Therapeutic options to prevent sepsis-associated immunopathology remain scarce. Here, we established a mouse model of long-lasting disease tolerance during severe sepsis, manifested by diminished immunothrombosis and organ damage in spite of a high pathogen burden. We found that both neutrophils and B cells emerged as key regulators of tissue integrity. Enduring changes in the transcriptional profile of neutrophils include upregulated Cxcr4 expression in protected, tolerant hosts. Neutrophil Cxcr4 upregulation required the presence of B cells, suggesting that B cells promoted disease tolerance by improving tissue damage control via the suppression of neutrophils’ tissue-damaging properties. Finally, therapeutic administration of a Cxcr4 agonist successfully promoted tissue damage control and prevented liver damage during sepsis. Our findings highlight the importance of a critical B-cell/neutrophil interaction during sepsis and establish neutrophil Cxcr4 activation as a potential means to promote disease tolerance during sepsis.
AB - Sepsis is a life-threatening condition characterized by uncontrolled systemic inflammation and coagulation, leading to multiorgan failure. Therapeutic options to prevent sepsis-associated immunopathology remain scarce. Here, we established a mouse model of long-lasting disease tolerance during severe sepsis, manifested by diminished immunothrombosis and organ damage in spite of a high pathogen burden. We found that both neutrophils and B cells emerged as key regulators of tissue integrity. Enduring changes in the transcriptional profile of neutrophils include upregulated Cxcr4 expression in protected, tolerant hosts. Neutrophil Cxcr4 upregulation required the presence of B cells, suggesting that B cells promoted disease tolerance by improving tissue damage control via the suppression of neutrophils’ tissue-damaging properties. Finally, therapeutic administration of a Cxcr4 agonist successfully promoted tissue damage control and prevented liver damage during sepsis. Our findings highlight the importance of a critical B-cell/neutrophil interaction during sepsis and establish neutrophil Cxcr4 activation as a potential means to promote disease tolerance during sepsis.
UR - https://www.scopus.com/pages/publications/85139536111
U2 - 10.7554/eLife.78291
DO - 10.7554/eLife.78291
M3 - Article
C2 - 36178806
AN - SCOPUS:85139536111
SN - 2050-084X
VL - 11
JO - eLife
JF - eLife
M1 - e78291
ER -